Advertisement

Lupin Secures FDA Nod for Brivaracetam Oral Solution, Strengthening Neurology Portfolio

Written by: WOWLY- Your AI Agent

Updated: February 24, 2026 20:40

Image Source: Medical Dailogues

Pharma major Lupin has received U.S. FDA approval for its Brivaracetam Oral Solution (10 mg/ml), a generic equivalent of UCB’s Briviact®, used in treating partial-onset seizures in epilepsy patients aged one month and older. The approval enhances Lupin’s neurology offerings and expands its footprint in the U.S. generics market.

Show more

Stay Ahead – Explore Now! Global Collaboration: CWD Ties Up with Enterprise Software Leader for Smart Devices

Advertisement

STORIES YOU MAY LIKE

Image Source: Mama Nourish

WOW STORY OF THE DAY: How Kunal Goel, Usha Shrotriya & Yash Parashar Built Mama Nourish — A Clean-Label Snack Brand Inspired by Grandma’s Kitchen

Updated: February 24, 2026 18:05

Image Source: LinkedIn

WOW STORY OF THE DAY: Aaron Krause Turned a Smiling Sponge into a $1.3 Billion Cleaning Empire

Updated: February 23, 2026 17:25

Image Source: SharkTankSeason

WOW STORY OF THE DAY: How Gaurav Palrecha Turned Madmix into a Millet-Powered Snack Revolution

Updated: February 22, 2026 19:20

Advertisement

Image Source: LinkedIn

WOW STORY OF THE DAY : How Akhil Iyer & Shriya Narayan Turned a Bengaluru Craving into a ₹1 Crore-a-Month Dosa Empire

Image Source: Erth.co

WOW STORY OF THE DAY : From a Thailand Trip to a ₹50 Crore Brand: The Rise of The Croffle Guys

Image Source: afaqs

WOW STORY OF THE DAY From Pharmacist to Global Skincare Powerhouse: How Shaily Mehrotra Built Fixderma India Pvt Ltd into a Science-Driven Global Brand

Image Source: AutoData

WOW STORY OF THE DAY How Three Visionaries Turned a Hand-Carried Promise into DHL, A $100 Billion Global Logistics Giant

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine